FDA advisory committee has recommended a booster dose of Moderna's COVID-19 vaccine

HomeU.S

FDA advisory committee has recommended a booster dose of Moderna's COVID-19 vaccine

BREAKING NEWS: FDA advisory committee has unanimously recommended a booster dose of Moderna's COVID-19 vaccine for those aged 65 and o

FDA advisory committee recommended approval of J&J vaccine
Jen Psaki insists it's Joe Biden right to kick Trump picks off military academy advisory boards
General Jack Keane calls Joe Biden 'petty' for kicking him off West Point advisory board


BREAKING NEWS: FDA advisory committee has unanimously recommended a booster dose of Moderna’s COVID-19 vaccine for those aged 65 and older and at high risk due to underlying conditions or their jobs

  • The FDA’s advisory committee has voted to recommend approval of Covid booster shots of Moderna’s vaccine
  • Boosters shots will only be approved for those aged 65 and older at high risk due to their jobs


An advisory committee for the U.S. Food and Drug Administration (FDA) has voted to recommend approval of booster doses of Moderna’s COVID-19.

The boosters have only been approved for older adults aged 65 and older and those who are at high risk of developing a severe case of the virus due to underlying conditions. 

It comes almost exactly one month after the Vaccines and Related Biological Products Advisory Committee (VRBPAC) approved boosters for the Pfizer-BioNTech vaccine 

The FDA's advisory committee has voted to recommend approval of Covid booster shots of Moderna's vaccine. Pictured: A healthcare worker holds a vial of the Moderna COVID-19 vaccine in New York City, January 2021

The FDA’s advisory committee has voted to recommend approval of Covid booster shots of Moderna’s vaccine. Pictured: A healthcare worker holds a vial of the Moderna COVID-19 vaccine in New York City, January 2021

Unlike Pfizer’s booster, which is merely a third dose of its vaccine, Moderna’s booster is a 50 microgram (µg) dose – half the dose of its original vaccine.

Previous data has shown the booster increased levels of neutralizing antibodies, including against the original virus and variants, including the Beta and Gamma variants. 

Last month, Moderna released data showing people who received its COVID-19 vaccine last year are nearly twice as likely to get a breakthrough infection compared to those recently vaccinated.    

There were 88 breakthrough cases of COVID-19 among Americans vaccinated from December 2020 to March 2021.

Comparatively, there were 162 cases – 1.8 times as many – among those vaccinated between July 2020 and December 2020.

The Cambridge, Massachusetts-based company said the data provided evidence for giving booster doses to fully vaccinated people. 

In August, the White House that COVID-19  vaccine booster shots would be rolled out for all Americans starting September 20.

At the time, the Biden administration released studies citing waning immunity and the ability of the Delta variant to cause breakthrough infections.

However, officials at the FDA and Centers for Disease Control and Prevention (CDC) pushed back, saying there wasn’t enough evidence that the efficacy of the vaccines were declining.

This lead to boosters for Pfizer’s vaccine not being rolled out until September 22 – past the targeted roll out date – and only for specific groups, just like Moderma.

Next, Moderna’s booster shot will be need to be authorized by the FDA and approved by the Centers for Disease Control and Prevention’s (CDC) advisory committee.

This is a breaking news story and will be updated. 

Advertisement

COMMENTS

WORDPRESS: 0
DISQUS: